MEC Resources (ASX:MMR)
With NSW in a gas shortage predicament that is significantly raising the price of this necessary resource, one $6.5 million capped company may have a solution.
Today’s company is making its mark by investing into exploration companies targeting potentially large energy and mineral resources.
Having recently opened a Share Purchase Plan, this company’s ambition is to be one of the only gas players to look offshore NSW.
To do so it has secured a vessel to start a seismic program to assist target drilling for natural gas.
The target is adjacent to Australia’s most populous region and the petroleum licence has the potential to hold 944 million barrels of oil equivalent as Prospective Resources of Natural Gas.
The information on this page should not be the only trigger for your investment decision. Click on the links below for a more in-depth and informed examination of the company. We strongly recommend you seek professional financial advice whenever making financial investment decisions.
Also of interest to investors is this company’s diversification strategy: it is hedging its bets on two very different sectors – energy, and biotech.
This company has stakes in a biotechnology player developing a pre-clinical model that can influence the development of liver cancer and has also taken a position in a technology that could assist anaesthetists to ensure patients remain properly sedated…
That’s a lot to think about, but at this stage it is the energy play which is this company’s main focus.
Can this company ease the looming gas burden in NSW…?
Can this ASX Micro Cap Reshape NSW Gas Supply with Looming Offshore Exploration Campaign?
May 2, 2016
Sydney may not be immediately aware, but the price of gas is about to start its upward journey. The rise is occurring because LNG plants in Queensland are sucking up all the gas and selling it to Asia.
ASX Junior’s Under-Drilled Cuban Oil Asset Puts it in Multi-Billion Barrel Company
Nov 15, 2018
Zero Safety Issues for IMU’s Immunotherapy Cancer Treatment: Phase II Trial Imminent
Nov 13, 2018